Cargando…

Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome

Background and Objectives: A growing number of epidemiological studies have suggested that diabetes mellitus may increase cancer risk and is implicated in numerous other metabolic and inflammatory disorders. The increase in proinflammatory cytokines plays a major role in insulin resistance and leads...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stan, Mihai Cosmin, Georgescu, Daniel, Mireștean, Ciprian Camil, Bădulescu, Florinel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453380/ https://www.ncbi.nlm.nih.gov/pubmed/37627906 http://dx.doi.org/10.3390/diagnostics13162647

Ejemplares similares

The Prognostic Value of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Head and Neck Low Grade Chondrosarcoma—A Rare Entity
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

An Underestimated Toxicity Radiation-Induced Hypothyroidism in Patients Multimodally Treated for Breast Cancer
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Image Guided Radiotherapy (IGRT) and Delta (Δ) Radiomics—An Urgent Alliance for the Front Line of the War against Head and Neck Cancers
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model—A Narrative Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon—A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Education in Radiation Oncology—Current Challenges and Difficulties
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review
por: Mireştean, Camil Ciprian, et al.
Publicado: (2022)

Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”
por: Mireştean, Camil Ciprian, et al.
Publicado: (2020)

New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Radiotherapy challenges in COVID era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Tourism at the Crossroads between Well-Being, Public Health and the Environment: Panel Data Evidence from the European Union
por: Badulescu, Daniel, et al.
Publicado: (2022)

Interleukin-1-Beta and Dyslipidemic Syndrome as Major Risk Factors for Thrombotic Complications in Type 2 Diabetes Mellitus
por: Bădulescu, Oana, et al.
Publicado: (2013)

MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Hemoperitoneum as a Life-Threatening Complication of an Acute Cholecystitis in a Patient with Hemophilia A with Inhibitors: A Case Report
por: Badulescu, Oana Viola, et al.
Publicado: (2022)

Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View
por: Rosca, Ciprian Ilie, et al.
Publicado: (2023)

The Crucial Role of Diet Therapy and Selenium on the Evolution of Clinical and Paraclinical Parameters in Patients with Metabolic Syndrome
por: Danciu, Adrian Marius, et al.
Publicado: (2023)

Moldova Region Population Study of Social Cases Affected by Partial Edentation
por: BIDA, FLORINEL COSMIN, et al.
Publicado: (2022)

Combination of Pentoxifylline and Ginko Biloba Nephroprotective Effect in Animal Models with Vancomycin-Induced Nephrotoxicity
por: POPA, ROMEO, et al.
Publicado: (2022)

Medical Tourism: Between Entrepreneurship Opportunities and Bioethics Boundaries: Narrative Review Article
por: BADULESCU, Daniel, et al.
Publicado: (2014)

The Relative Effects of Economic Growth, Environmental Pollution and Non-Communicable Diseases on Health Expenditures in European Union Countries
por: Badulescu, Daniel, et al.
Publicado: (2019)

A Novel Algorithm for Evaluating Bone Metastatic Potential of Breast Cancer through Morphometry and Computational Mathematics
por: Duca-Barbu, Simona-Alina, et al.
Publicado: (2023)

Risk factors predicting the development of diabetes mellitus and metabolic syndrome following gestational diabetes mellitus
por: CAN, Bülent, et al.
Publicado: (2021)

An Observational Study on Oral Health and Quality of Life for RPD Wearers in the N-E Region of Romania
por: Bida, Florinel Cosmin, et al.
Publicado: (2022)

Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
por: Olariu, Mihai, et al.
Publicado: (2013)

Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?
por: Georgescu, Doina, et al.
Publicado: (2023)

Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients
por: Georgescu, Doina, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on patients with primary Sjögren syndrome
por: Serban, Augustin, et al.
Publicado: (2021)

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
por: Davies, Michael J, et al.
Publicado: (2017)

Fibroblast Growth Factor 21 Predicts the Metabolic Syndrome and Type 2 Diabetes in Caucasians
por: Bobbert, Thomas, et al.
Publicado: (2013)

Cardiovascular Risk Factors in Patients with Congenital Hemophilia: A Focus on Hypertension
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium
por: Corb Aron, Raluca Anca, et al.
Publicado: (2021)

Chemical sensors and biosensors: fundamentals and applications
por: Banica, Florinel-Gabriel
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4af1dr3achjnrasl83kmi7k45e